STRATEGIC GROWTH IN
HEMATOLOGY AND ONCOLOGY SERVICES
The Phoenix Children’s Center for Cancer and Blood Disorders programs treat a wide range of complex conditions, including solid tumors, leukemia, hemophilia, sickle cell disease and histiocytosis. Services are being expanded in all of these areas, with more dedicated specialists coming on board to address specific components of disease and focus on developing innovative treatments.
Rapid growth is happening in several key areas, including immunology, transplants for nonmalignant issues such as genetic and immunodeficiency disorders, and clinical research in solid tumor, leukemia and neuro-oncology.
The Center will be expanding the scope of its clinical services and strengthening its medical team primarily through:
ADVANCING CLINICAL TRIALS RESEARCH
Building on recent developments that include partial-match transplants to expand therapy options for sickle cell patients, the Center is stepping up involvement in translational research in the sarcoma, leukemia and neuro-oncology labs.
CREATING NEW DEDICATED PROGRAMS
The Center aims to develop specialty areas focused on cancer genetics, neurocutaneous disorders, neurofibromatosis and young adult/ adolescent health.
RECRUITING NEW TALENT
Searches are currently in process for leadership positions and physician specialists in multiple areas, including researchers to spearhead clinical trials and treatment development.
“We’ve had the honor of meeting so many patients with cancer whose lives were saved at Phoenix Children’s. Some of the older ones we’ve kept in touch with and watched them go on to do remarkable things. That’s why we’re so proud to support this hospital.”